Hims & Hers Health, Inc. (HIMS)

$27.71 close · Sep 05, 2026

Below 50 & 200 SMA

52W -39.0% from High

Our Estimate

$223.80 – $223.80 Wide range

At $29.58, the market is pricing in roughly 10% sustained revenue growth. This is a hypergrowth company reinvesting ahead of GAAP profits, so our revenue-and-margin methods put fair value in the range above — below today's price. A high-expectations growth stock, not a broken model.

Mixed

3M6M1YAll

Cross-Check: Greenblatt Magic Formula

Revenue ?Total sales generated from the company's primary business activities over the trailing twelve months.	2.58B
Gross Profit ?Revenue minus cost of goods sold. What remains before operating expenses — reflects pricing power and production efficiency.	1.76B
Operating Income ?Profit from core business operations after all operating expenses (EBIT). Excludes interest and taxes.	-154.5M
Net Income ?Bottom-line profit after all expenses, interest, and taxes are deducted from revenue.	-142.0M
Free Cash Flow ?Operating cash flow minus capital expenditures. The actual cash the business generates after maintaining its assets — the truest measure of profitability.	238.5M
EBITDA ?Earnings before interest, taxes, depreciation & amortization. A proxy for operating cash earnings that strips out accounting and financing differences.	-67.3M
Total Debt ?Combined short-term and long-term interest-bearing debt obligations. Compare against cash and earnings to gauge leverage risk.	—
Cash & Equivalents ?Highly liquid assets on hand — cash, money market funds, and short-term securities. The company's immediate financial cushion.	609.8M

Market Cap	6.42B
Enterprise Value	5.99B
EV / Revenue	2.3x
EV / EBITDA	-89.0x
P/E (TTM)	-45.2x
Forward P/E	—
PEG	—
P/FCF	26.9x
FCF Yield	3.7%

Gross Margin ?Gross profit as a % of revenue. Measures how efficiently the company produces its goods or services — higher is better.	68.4%
EBITDA Margin ?EBITDA as a % of revenue. Shows core operating profitability before accounting adjustments — useful for comparing across industries.	-2.6%
Net Margin ?Net income as a % of revenue. The ultimate measure of overall profitability after every expense, interest payment, and tax is accounted for.	-5.5%
FCF Margin ?Free cash flow as a % of revenue. Shows how much of each dollar of revenue converts into real, spendable cash.	9.3%
Revenue Growth (YoY) ?Year-over-year change in total revenue. Measures business momentum — sustained growth above 15% is typically considered strong.	28.0%
Net Income Growth (YoY) ?Year-over-year change in net income. Shows whether profits are growing faster or slower than revenue — a key indicator of improving or deteriorating quality.	-173.4%
Piotroski F-Score ?Score from 0–9 measuring financial strength across profitability, leverage, and efficiency signals. 8–9 = strong, 0–2 = distressed.	3 / 9
Altman Z-Score ?Bankruptcy risk model. Above 2.99 = safe zone, 1.81–2.99 = grey zone, below 1.81 = distress signal. Most useful for manufacturing companies.	0.72

3M6M1YAll

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25	Q4 '25	Q3 '25	Q2 '25	Q1 '25	Q4 '25	Q3 '24
Revenue ?Total quarterly sales from primary business operations.	753.2M	608.1M	617.8M	599.0M	544.8M	586.0M	481.1M	401.6M	315.6M	278.2M	246.6M	226.7M
Gross Profit ?Quarterly revenue minus cost of goods sold.	480.8M	396.8M	444.4M	442.1M	416.2M	430.7M	369.5M	317.9M	256.6M	229.1M	204.1M	187.3M
Operating Income ?Quarterly profit from core operations before interest and taxes (EBIT).	-97.2M	-78.3M	9.2M	11.8M	26.7M	57.9M	18.6M	22.4M	11.0M	9.9M	-$400,000	-8.6M
Net Income ?Quarterly bottom-line profit after all expenses and taxes.	-86.3M	-92.1M	20.6M	15.8M	42.5M	49.5M	26.0M	75.6M	13.3M	11.1M	1.2M	-7.6M
FCF ?Quarterly free cash flow: operating cash minus capital expenditures.	-43.8M	80.5M	72.9M	128.8M	-25.1M	98.1M	79.3M	85.8M	52.9M	25.2M	23.8M	20.4M

3M6M1YAll

3M6M1YAll

Shaded region = bear-to-bull DCF range. Line = actual market cap.